Transforming addiction treatment

CA Bridge saves lives by making it possible for people who use drugs to get treatment at any hospital—whenever and wherever they need it.

Dr. Leslie Mukau, Medical Director for the Emergency Department El Centro Regional Medical Center at a CA Bridge training.

Treat a Patient

While you’re on-shift/on-service.

Find Treatment

To help with your drug use.

MAT During COVID-19

Medication for Addiction Treatment During COVID-19

As overdose rates rise, we need addiction treatment in hospitals now more than ever. This guidance outlines how to implement medication for addiction treatment (MAT) during predicted COVID-19 surges.

CA Bridge Graphic

New HHS Practice Guidelines

Here’s the most important takeaway of the “HHS Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder”: All prescribers with a valid state license and DEA can register for an X wavier without mandatory training.

Blueprint Image

Blueprint for Hospital Opioid Use Disorder Treatment

This comprehensive resource is scalable for any health system, based on our model implemented at diverse sites that demonstrate feasibility at large and small, public and private, urban, and rural hospitals.


Buprenorphine Starts for Fentanyl Use

3 Feb 2022, 11:00 am

Emerging Trends Training Series

Presenters: Hannah Snyder, MD & Erik Andersen, MD

Facts vs Fear: As fentanyl spreads in many communities, buprenorphine is still an effective tool for treating patients with just a few clinical tweaks.


Explore our collection of resources developed by an interdisciplinary team based on published evidence, best practices from the field and expert opinion.


Learn more about how the implementation of medication for addiction treatment (MAT) from the hospital setting can save tens of thousands of lives.